Voltammetric quantification, spectroscopic, and DFT studies on the binding of the antineoplastic drug Azacitidine with DNA

Copyright © 2023. Published by Elsevier B.V..

In this study, experimental studies were carried out to explore the action mechanism of the anti-cancer drug Azacitidine on the double-stranded DNA (dsDNA). The drug binding constant (Kb) was found to be 4.13 ± 0.23 × 105 M-1 using voltammetric measurements and 1.67 ± 0.24 × 105 M-1 using the fluorescence spectroscopy. Both values are close to the values of 2.04 ± 0.30 × 105 M-1 for deoxyguanosine (dGuO) and 1.23 ± 0.30 × 105 M-1 for deoxyadenosine (dAdo). In the displacement studies, the ethidium bromide, strong DNA intercalator, was replaced by the Azacitidine, hence caused a decrease on the fluorescence emission intensity. In thermal denaturation studies, the increase of 8.60 °C in the melting temperature upon introduction of the Azacitidine into the dsDNA solution cleary indicated intercalation binding mode of the drug. The experimental and theoretical IR spectra of Azacitidine, dsDNA and their H-bonded complex were confirmed the Azacitidine's intercalation ability to induce cytotoxicity. We also developed a method for the detection of Azacitidine at low concentrations using the differential pulse voltammetry (DPV). The peak current decreases in the oxidation signals of the deoxyguanosine obtained voltammetrically upon the interaction of Azacitidine and dsDNA allowed a sensitive determination of Azacitidine in pH 4.80 acetate buffer. A linear dependence of the deoxyguanosine oxidation signals was observed within the range of 2-20 µM Azacitidine, with a limit of detection (LOD) 0.62 µM.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

2023

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:237

Enthalten in:

Journal of pharmaceutical and biomedical analysis - 237(2023) vom: 05. Jan., Seite 115746

Sprache:

Englisch

Beteiligte Personen:

Şenel, Pelin [VerfasserIn]
Agar, Soykan [VerfasserIn]
Yurtsever, Mine [VerfasserIn]
Gölcü, Ayşegül [VerfasserIn]

Links:

Volltext

Themen:

9007-49-2
Antineoplastic Agents
Azacitidine
DNA
Deoxyguanosine
Determination
DsDNA
G9481N71RO
Guanin
Intercalation
Journal Article
M801H13NRU
Pharmaceutical dosage form
Review
Spectroscopy
Voltammetry

Anmerkungen:

Date Completed 03.11.2023

Date Revised 03.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jpba.2023.115746

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363551948